期刊文献+

基于快速CYP2C19基因检测发现携带功能缺失等位基因的急性轻型缺血性卒中双抗治疗1例报道 被引量:1

Dual Antiplatelet Therapy for Acute Minor Ischemic Stroke in Loss-of-function Carriers Based on Rapid CYP2C19 Genotyping:A Case Report
下载PDF
导出
摘要 1病例介绍患者男性,73岁,农民。主诉“言语不清伴右侧肢体麻木无力4.5小时”,于2021年11月2日入院。患者于入院前4.5 h吃饭时突然出现言语不清,但语句尚连贯,伴右侧肢体无力,右面部及右上、下肢麻木不适,右上肢抬举及持物尚可,右下肢行走无明显拖拽。无头晕、头痛、恶心、呕吐,无声音嘶哑,无视物模糊、变形、闪光,无耳鸣、耳聋、听力下降,无肢体抽搐,无意识障碍。为求系统诊治来我院就诊,门诊以“缺血性卒中”收入院。
作者 冯博 赵彩君 常立国 FENG Bo;ZHAO Caijun;CHANG Liguo
出处 《中国卒中杂志》 2022年第8期817-820,共4页 Chinese Journal of Stroke
  • 相关文献

参考文献3

二级参考文献52

  • 1Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 2Kelly RP, Close SL, Farid NA, Witers K J, Shen L, Natanegara F, et al. Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants. BrJ Clin Pharmaco12012; 73: 93-105.
  • 3Boggon R, van Staa TP, Timmis A, Hemingway H, Ray KK, Begg A, et al. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction -- a hospital registry - primary care linked cohort (MINAP- GPRD). Eur Heart J 2011; 32: 2376-86.
  • 4Perry CG, Shuldiner AR. Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation? J Hum Genet 2013: 58: 339-45.
  • 5Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coil Cardiol 2005; 45: 1157-64.
  • 6Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topoi EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coil Cardiol 2005; 45: 246-51.
  • 7Ford NF. Clopidogrel resistance: pharmacokinetic or pharmaco- genetic? J Clin Pharmacol 2009; 49: 506-12.
  • 8Hasan MS, Basri HB, Hin LP, Stanslas J. Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention. Int J Neurosci 2013; 123: 143-54.
  • 9Jiang XL, Samant S, Lesko U, Schmidt S. Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clin Pharmacokinet 2015; 54: 147 - 66.
  • 10Kazui M, Nishiya Y, Ishizuka 1, Hagihara K, Farid NA, Okazaki O, et al. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos 2010; 38: 92-9.

共引文献1429

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部